Zobrazeno 1 - 10
of 240
pro vyhledávání: '"T, Delozier"'
Autor:
Joseph Gligorov, J-P Borg, Emmanuelle Charafe-Jauffret, Henri Roché, I Ben Younes, A. Gonçalves, Patrice Viens, Thomas Bachelot, M. Campone, Thierry Petit, J-M Ferrero, Florence Lerebours, J-Y Pierga, T. Delozier, Luc Camoin
Publikováno v:
Cancer Research. 73:P6-12
Background Inflammatory breast cancer (IBC) is a rare but aggressive form of locally advanced breast cancer, the optimal systemic treatment of which is still discussed. Beverly 2 trial was a phase II study evaluating the efficacy and safety of a preo
Autor:
M-A Mouret-Reynier, Thierry Petit, J-Y Pierga, Jérôme Lemonnier, Thomas Bachelot, T. Delozier, Patrick Soulié, Florence Lerebours, J. Bonneterre, E Charafe-Jauffret, J-M Ferrero, A-C. Hardy-Bessard, J.M. Boher, Bernard Asselain, P. Kerbrat, Gilles Romieu, J-C Eymard, A-L Martin, Florence Dalenc, M Deblock, Alain Lortholary, F Andre, Patrice Viens
Publikováno v:
Cancer Research. 71:P4-20
Background: Inflammatory breast cancer (IBC) is a relatively rare form of breast cancer. Because this disease exhibits angiogenic properties, bevacizumab (BEV) may improves the efficacy of neoadjuvant chemotherapy (CT) in IBC. Methods: Pts with HER2
Autor:
Patrice Viens, P. Kerbrat, J-M Ferrero, F-C Bidard, Jérôme Lemonnier, Gilles Romieu, Florence Dalenc, Thierry Petit, J-Y Pierga, J. Bonneterre, F Andre, T. Delozier
Publikováno v:
Cancer Research. 71:P1-14
Background: Prognostic value of CTC detection in blood has been reported in primary breast cancer with a rate around 20% in the neoadjuvant setting. No correlation between CTC and pCR to neoadjuvant CT in operable breast cancer has been reported (Pie
Autor:
T. Delozier
Publikováno v:
Journal de Gynécologie Obstétrique et Biologie de la Reproduction. 39:F71-F78
Journal de Gynecologie Obstetrique et Biologie de la Reproduction - Vol. 39 - N° 8S - p. F71-F78
Autor:
Joseph Gligorov, Thierry Petit, Thomas Bachelot, M. Campone, J-Y Pierga, L Kockler, J-M Ferrero, T. Delozier, E. Charafe-Jauffrete, Patrice Viens, H. Roche, Florence Lerebours
Publikováno v:
Cancer Research. 70:P2-16
Background: The efficacy of first-line CT for HER2-negative metastatic breast cancer is significantly improved by combining CT with BEV, as shown in three randomized phase III trials. In HER2-positive breast cancer, the role of H is established but t
Autor:
C Leger-Falandry, J-M Ferrero, Thomas Bachelot, C El Kouri, Claire Cropet, J-P Guastalla, Céline Bourgier, Marc Debled, Patrick Soulié, Eric Legouffe, J-C Eymard, Dominique Spaeth, T. Delozier, J. Chidiac
Publikováno v:
Cancer Research. 70:S1-6
Background: Resistance to hormonal therapy may be associated with activation of the PI3K/AKT pathway. Preclinically, everolimus (RAD), an oral inhibitor of mTOR, has been shown to reverse resistance to tamoxifen (TAM). In a prior randomized phase II
Autor:
Patrice Viens, Joseph Gligorov, Thierry Petit, M. Campone, F-C Bidard, S Kraemer, Claire Mathiot, T. Delozier, H. Roche, Florence Lerebours, J-M Ferrero, J-Y Pierga
Publikováno v:
Cancer Research. 70:PD04-07
Introduction: CTC detection in peripheral blood is an independent prognostic factor in early breast cancer but with a low detection rate of 10% to 23% of the patients (B. Rack, ASCO 2010, FC Bidard, Ann Oncol 2010). Changes in the HER2 status of CTC
Autor:
Pascale Romestaing, Thomas Bachelot, D. Mille, Eric Pujade-Lauraine, Marc Debled, Benoit You, Gilles Freyer, L. Mauriac, Claire Falandry, J. Cretin, T. Delozier
Publikováno v:
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, Springer Verlag, 2008, 116 (3), pp.501-508. ⟨10.1007/s10549-008-0229-5⟩
Breast Cancer Research and Treatment, Springer Verlag, 2008, 116 (3), pp.501-508. ⟨10.1007/s10549-008-0229-5⟩
International audience; The aim of this study was to evaluate antitumor effects of cyclooxygenase-2 inhibitors in breast carcinoma and their ability to act synergistically with aromatase inhibitors (AIs). Postmenopausal metastatic breast cancer patie
Autor:
Jacques Bonneterre, R. Arriagada, Catherine Hill, L. Mauriac, M. Spielmann, Monique G. Lê, T. Delozier, T. Tursz, Moïse Namer
Publikováno v:
Annals of Oncology. 16:389-396
Purpose: The aim of this multicenter trial was to evaluate the role of ovarian suppression in patients with early breast cancer previously treated with local surgery and adjuvant chemotherapy. Patients and methods: Nine hundred and twenty-six premeno
Autor:
T Delozier
Publikováno v:
European Journal of Cancer. 36:1902-1905